asia vets wearable device category is expanding rapidly, and the related industry chain is expected to experience explosive growth.

Huajin Securities stated that with the development of technology, the categories of wearable devices are also expanding rapidly. Wearable devices continue to evolve, and the related industry chain is expected to experience explosive growth.

cls.cnSep 2 07:54

Did Softcom Power's loss of 0.154 billion in the first half of the year enable the company's performance in the long term? | Interpretations

In the first half of 2024, Pactera achieved revenue of 12.526 billion yuan, a year-on-year increase of 45.98%; net loss attributable to the parent company was 0.154 billion yuan, a year-on-year decrease of 176.17%; Under the wave of AI at the edge, the revenue generated in the high-tech and manufacturing field reached 4.094 billion yuan, a year-on-year increase of 268.73%.

cls.cnAug 29 23:34

Sanbo Brain H1 net profit increased by more than 50% year-on-year, industry attention on expansion phase performance sustainability | Interpretations

①In the first half of this year, Sanbo Neurology achieved double growth in operating profit, mainly due to the expansion of the business scale and the increase in net income from acquiring companies; ② Sanbo Neurology is building two hospitals and plans to focus on the future expansion in the cni yangtze index and cni zhujiang index regions; ③ The industry is concerned about the sustainability of its expansion, the construction capabilities of the diagnostic and treatment team, and the relatively scarce professional talents in neurology.

cls.cnAug 28 01:03

Lepu Medical Technology's performance continued to decline in the first half of the year. It is expected that the revenue of the formulated business will further decrease. | Interpretations

① lepu medical technology once again submitted a half-year report with a decline in performance, and the revenue of the company's three major business sectors decreased year-on-year. ② Due to reasons such as the aging of product pipelines, lepu medical technology determines that the revenue of the formulation business sector may decrease to around 1.5 billion-1.6 billion yuan. ③ The company conducted self-inspection and rectification in response to the issues and requirements raised in the administrative supervision and regulation measures decision issued by the Beijing Securities Regulatory Bureau.

cls.cnAug 23 23:56

Hybio Pharmaceutical's H1 revenue continues to decline. Have active pharmaceutical ingredient orders become a "lifesaver"? | Interpretations

①In the first half of this year, hybio pharmaceutical's revenue decline trend has not stopped, and the net profit loss has narrowed to a certain extent; ②The formulation sector has been affected by block orders, with continuous revenue decline, and the active pharmaceutical ingredient sector has become the top revenue contributor; ③In the first half of this year, with efforts from multiple parties, hybio pharmaceutical has seen some relief in cash flow.

cls.cnAug 23 20:58

Star evening news | After No. 9 company's de-Xiaomi transformation, net profit in the first half of the year increased by over 167% year-on-year. Qingdao Haier Biomedical Co., Ltd.'s shareholder intends to inquire about transferring 2% of its shares.

1. The SASAC: fully exert the role of central enterprise block orders in key areas of technological innovation procurement and use; 2. Three departments: carry out collaborative planning and layout of computing power and electrical utility infrastructure; 3. MIIT: steadily promote the reform of the satellite internet plus-related business access system.

cls.cnAug 6 20:40